共 50 条
Dasatinib-induced hypoglycemia in a patient with acute lymphoblastic leukemia
被引:5
作者:
Lundholm, Michelle D.
[1
]
Charnogursky, Gerald A.
[2
]
机构:
[1] Loyola Univ Med Ctr, Dept Internal Med, 2160 S First Ave, Maywood, IL 60153 USA
[2] Loyola Univ Hlth Care Syst, Dept Med, Div Endocrinol, Maywood, IL USA
来源:
CLINICAL CASE REPORTS
|
2020年
/
8卷
/
07期
关键词:
acute lymphoblastic leukemia;
adverse effect;
diabetes;
hypoglycemia;
tyrosine kinase inhibitor;
CHRONIC MYELOID-LEUKEMIA;
TYROSINE KINASE INHIBITORS;
IMATINIB MESYLATE;
GLUCOSE;
D O I:
10.1002/ccr3.2901
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Tyrosine kinase inhibitors can cause significant hypoglycemia in patients with diabetes on other antihyperglycemic medications. These patients should be monitored, and their medications adjusted accordingly.
引用
收藏
页码:1238 / 1240
页数:3
相关论文
共 50 条